ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

Organ Systems Programs “Filling the Gaps” With Targeted Research

January 23, 1987

ACCC Members Find Few Answers, Many Problems

February 7, 1975